Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 31;10(2):75.
doi: 10.3390/brainsci10020075.

Using Light for Therapy of Glioblastoma Multiforme (GBM)

Affiliations
Review

Using Light for Therapy of Glioblastoma Multiforme (GBM)

Alex Vasilev et al. Brain Sci. .

Abstract

: Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumour with extremely poor prognosis. The current standard of care for newly diagnosed GBM includes maximal surgical resection followed by radiotherapy and adjuvant chemotherapy. The introduction of this protocol has improved overall survival, however recurrence is essentially inevitable. The key reason for that is that the surgical treatment fails to eradicate GBM cells completely, and adjacent parenchyma remains infiltrated by scattered GBM cells which become the source of recurrence. This stimulates interest to any supplementary methods which could help to destroy residual GBM cells and fight the infiltration. Photodynamic therapy (PDT) relies on photo-toxic effects induced by specific molecules (photosensitisers) upon absorption of photons from a light source. Such toxic effects are not specific to a particular molecular fingerprint of GBM, but rather depend on selective accumulation of the photosensitiser inside tumour cells or, perhaps their greater sensitivity to the effects, triggered by light. This gives hope that it might be possible to preferentially damage infiltrating GBM cells within the areas which cannot be surgically removed and further improve the chances of survival if an efficient photosensitiser and hardware for light delivery into the brain tissue are developed. So far, clinical trials with PDT were performed with one specific type of photosensitiser, protoporphyrin IX, which tends to accumulate in the cytoplasm of the GBM cells. In this review we discuss the idea that other types of molecules which build up in mitochondria could be explored as photosensitisers and used for PDT of these aggressive brain tumours.

Keywords: glioblastoma multiforme; photodynamic therapy; photosensitiser.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Basic mechanisms of photodynamic therapy (PDT) and its potential targets in mitochondria. MMP—Mitochondrial membrane potential, MPTP—mitochondrial transition pore.

References

    1. Jiang Y., Uhrbom L. On the origin of glioma. Ups. J. Med. Sci. 2012;117:113–121. doi: 10.3109/03009734.2012.658976. - DOI - PMC - PubMed
    1. Florian I.S., Ungureanu G., Berce C. Risk factors for gliomas. An extensive review. Rom. Neurosurg. 2013;20:5–21. doi: 10.2478/v10282-012-0016-z. - DOI
    1. Ostrom Q.T., Bauchet L., Davis F.G., Deltour I., Fisher J.L., Langer C.E., Pekmezci M., Schwartzbaum J.A., Turner M.C., Walsh K.M., et al. The epidemiology of glioma in adults: A state of the science review. Neuro-Oncology. 2014;16:896–913. doi: 10.1093/neuonc/nou087. - DOI - PMC - PubMed
    1. Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803–820. doi: 10.1007/s00401-016-1545-1. - DOI - PubMed
    1. Perry A., Wesseling P. Handbook of Clinical Neurology. Vol. 134. Elsevier; Amsterdam, The Netherlands: 2016. Histologic classification of gliomas; pp. 71–95. - PubMed

LinkOut - more resources